Overview Maxi-Analgesic Osteoarthritis (OA) Study Status: Withdrawn Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary The purpose of this study is to determine whether the analgesic effects of Maxigesic USA are greater than acetaminophen, ibuprofen or placebo in patients who have painful osteoarthritis of the hip or knee. Phase: Phase 3 Details Lead Sponsor: AFT Pharmaceuticals, Ltd.Treatments: AcetaminophenAnalgesicsIbuprofen